1.
Clin Exp Dermatol
; 44(7): 801-803, 2019 Oct.
Article
in English
| MEDLINE
| ID: mdl-30610768
Subject(s)
Acneiform Eruptions/pathology , Lupus Erythematosus, Systemic/pathology , Skin Diseases/immunology , Acneiform Eruptions/etiology , Antirheumatic Agents/administration & dosage , Antirheumatic Agents/therapeutic use , Female , Foot/pathology , Glucocorticoids/administration & dosage , Glucocorticoids/therapeutic use , Humans , Hydroxychloroquine/administration & dosage , Hydroxychloroquine/therapeutic use , Lupus Erythematosus, Systemic/complications , Lupus Erythematosus, Systemic/drug therapy , Neutrophils/pathology , Pain/diagnosis , Prednisone/administration & dosage , Prednisone/therapeutic use , Skin Diseases/pathology , Treatment Outcome , Young Adult
2.
Int J Womens Dermatol
; 3(2): 91-95, 2017 Jun.
Article
in English
| MEDLINE
| ID: mdl-28560302
ABSTRACT
Localized cutaneous nodular amyloidosis (LCNA) is the rarest form of localized cutaneous amyloidosis. In patients with LCNA, local plasma cells secrete immunoglobulin light chains called amyloid L via an unknown mechanism. LCNA has been associated with autoimmune connective tissue diseases such as most commonly Sjögren syndrome. A few reported cases of LCNA are associated with limited systemic sclerosis (LSSc). We report three cases of LCNA in patients with LSSc to add to the existing literature, discuss the disease association and proposed pathophysiology, and briefly review the existing information in current literature. It is important to closely follow patients with LCNA to monitor progression to systemic amyloidosis.
3.
Clin Exp Dermatol
; 39(5): 661-3, 2014 Jul.
Article
in English
| MEDLINE
| ID: mdl-24888435